Total Payments
$1,413
2024 Payments
$215.44
Companies
26
Transactions
112
Medicare Patients
5,218
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$1,413 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,413 | 112 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $281.18 | 59 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $259.40 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $192.89 | 4 | $0 (2023) |
| Insmed, Inc. | $98.89 | 5 | $0 (2023) |
| ABBVIE INC. | $81.81 | 3 | $0 (2024) |
| Shire North American Group Inc | $66.32 | 4 | $0 (2017) |
| GlaxoSmithKline, LLC. | $62.78 | 4 | $0 (2019) |
| Theravance Biopharma Inc. | $54.75 | 4 | $0 (2017) |
| Gilead Sciences, Inc. | $36.99 | 2 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $28.94 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $215.44 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($61.24) |
| 2023 | $171.43 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($103.39) |
| 2022 | $298.07 | 7 | Merck Sharp & Dohme LLC ($144.38) |
| 2021 | $17.71 | 1 | Insmed, Inc. ($17.71) |
| 2019 | $103.69 | 7 | GlaxoSmithKline, LLC. ($17.75) |
| 2018 | $193.19 | 36 | PFIZER INC. ($111.38) |
| 2017 | $413.90 | 46 | PFIZER INC. ($121.02) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 2 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.30 | General |
| 05/06/2019 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/06/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2019 | Melinta Therapeutics, Inc. | Vabomere (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: ANTIBIOTICS | ||||||
| 01/05/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Obesity | ||||||
| 12/17/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Virology & Specialty Care | ||||||
| 12/10/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.55 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 12/03/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 11/05/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/22/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/08/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $5.63 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/20/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/04/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $6.09 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/20/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/06/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 07/19/2018 | Horizon Pharma plc | KRYSTEXXA (Drug) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: KRYSTEXXA | ||||||
| 07/16/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.55 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 07/02/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 06/06/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/29/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/14/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/08/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $1.97 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/30/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/26/2018 | PFIZER INC. | LYRICA (Drug), EMBEDA, FLECTOR PATCH | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,360 | 9,523 | $850,004 | $349,114 |
| 2022 | 20 | 1,247 | 48,568 | $723,134 | $283,394 |
| 2021 | 18 | 1,237 | 14,991 | $720,050 | $330,423 |
| 2020 | 15 | 1,374 | 4,468 | $714,602 | $322,114 |
Total Patients
5,218
Total Services
77,550
Medicare Billing
$1.3M
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1335 | Injection, ertapenem sodium, 500 mg | Office | 2022 | 11 | 125 | $9,625 | $1,432 | 14.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 37 | 79 | $2,371 | $783.51 | 33.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 37 | 88 | $1,748 | $633.30 | 36.2% |
| 86140 | Measurement c-reactive protein for detection of infection or inflammation | Office | 2022 | 37 | 90 | $894.00 | $443.01 | 49.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 46 | $1,520 | $417.72 | 27.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 14 | 664 | $6,360 | $255.14 | 4.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 18 | 24 | $552.00 | $185.49 | 33.6% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2022 | 15 | 36 | $648.00 | $136.98 | 21.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2022 | 21 | 34 | $280.00 | $130.82 | 46.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 30 | 34 | $198.00 | $100.32 | 50.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 376 | 2,718 | $407,700 | $174,110 | 42.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 243 | 292 | $87,600 | $52,084 | 59.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 30 | 2,640 | $90,301 | $41,947 | 46.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 145 | 161 | $40,250 | $18,774 | 46.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 189 | $21,546 | $12,883 | 59.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 103 | $17,510 | $9,946 | 56.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 25 | 153 | $19,584 | $8,248 | 42.1% |
| 96374 | Injection of drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 16 | 153 | $15,147 | $5,110 | 33.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $5,418 | $2,736 | 50.5% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2021 | 11 | 7,000 | $7,000 | $1,137 | 16.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 25 | 55 | $990.00 | $570.24 | 57.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 32 | 70 | $1,120 | $543.90 | 48.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 11 | 14 | $1,372 | $543.75 | 39.6% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 11 | 1,192 | $1,192 | $525.02 | 44.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 30 | 44 | $1,760 | $452.40 | 25.7% |
About Dr. James Gordon, M.D
Dr. James Gordon, M.D is a Infectious Disease healthcare provider based in Novi, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144239559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Gordon, M.D has received a total of $1,413 in payments from pharmaceutical and medical device companies, with $215.44 received in 2024. These payments were reported across 112 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($1,413).
As a Medicare-enrolled provider, Gordon has provided services to 5,218 Medicare beneficiaries, totaling 77,550 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Novi, MI
- Active Since 08/05/2006
- Last Updated 01/11/2021
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144239559
Products in Payments
- CUVITRU (Biological) $325.72
- LYRICA (Drug) $195.54
- VAXNEUVANCE (Biological) $144.38
- Arikayce (Drug) $98.89
- VIBATIV (Drug) $54.75
- TEFLARO (Drug) $54.35
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $53.91
- TRELEGY ELLIPTA (Drug) $36.20
- REBYOTA (Biological) $28.94
- AVYCAZ (Drug) $27.46
- Saxenda (Drug) $24.90
- LINZESS (Drug) $22.90
- DIFICID (Drug) $18.21
- ZEPATIER (Drug) $18.16
- NUZYRA (Drug) $17.11
- ELIQUIS (Drug) $16.57
- EMBEDA (Drug) $16.04
- Vabomere (Drug) $15.99
- ANORO (Drug) $15.91
- XARELTO (Drug) $15.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.